The invention is directed to purified and isolated novel ACPL polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.

 
Web www.patentalert.com

> Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of DMS

~ 00378